Immunosenescence does not abrogate engraftment of murine allogeneic bone marrow

Transplantation

Volumn 95, Issue 12, 2013, Pages 1431-1438

  Hock, Karin ^a,b   Oberhuber, Rupert ^a,c   Lee, Ying Lung ^a   Wrba, Fritz ^b   Wekerle, Thomas ^b   Tullius, Stefan G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Immunosenescence; Mixed chimerism; Transplantation tolerance

Indexed keywords

GAMMA INTERFERON; RAPAMYCIN;

AGE; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CHIMERA; CONTROLLED STUDY; ENGRAFTMENT; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; GRAFT RECIPIENT; HEART GRAFT; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOSENESCENCE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; NONMYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; SENESCENCE; SKIN GRAFT; T CELL DEPLETION; WHOLE BODY RADIATION;

AGING; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CYTOKINES; FEMALE; FLOW CYTOMETRY; IMMUNOLOGIC MEMORY; LYMPHOCYTE DEPLETION; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHENOTYPE; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION TOLERANCE;

EID: 84880135648     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182954618     Document Type: Article

References (51)

1. Sorror ML, Sandmaier BM, Storer BE, et al. Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hemato-logic malignancies. JAMA 2011; 306: 1874.
2. Shapira MY, Resnick IB, Bitan M, et al. Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients. Bone Marrow Transplant 2004; 34: 155.
3. Nikolich-Zugich J. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol 2008; 8: 512.
4. Haynes L, Eaton SM, Burns EM, et al. CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly. Proc Natl Acad Sci USA 2003; 100: 15053.
5. Heeger PS, Greenspan NS, Kuhlenschmidt S, et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163: 2267.
6. Adams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111: 1887.
7. Yamada Y, Boskovic S, Aoyama A, et al. Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates. Am J Transplant 2012; 12: 330.
8. Wu Z, Bensinger SJ, Zhang J, et al. Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med 2004; 10: 87.
9. Ford ML, Kirk AD, Larsen CP. Donor-reactive T-cell stimulation history and precursor frequency: barriers to tolerance induction. Transplantation 2009; 87: S69.
10. Xu H, Chilton PM, Tanner MK, et al. Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients. Blood 2006; 108: 3611.
11. Pilat N, Wekerle T. Transplantation tolerance through mixed chime-rism. Nat Rev Nephrol 2010; 6: 594.
12. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353.
13. Leventhal J, Abecassis M, Miller J, et al. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med 2012; 4: 124ra128.
14. Millan MT, Shizuru JA, Hoffmann P, et al. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 2002; 73: 1386.
15. Blaha P, Bigenzahn S, Koporc Z, et al. The influence of immunosup-pressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 2003; 101: 2886.
16. Wekerle T, Sayegh MH, Hill J, et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 1998; 187: 2037.
17. Taylor PA, Lees CJ, Wilson JM, et al. Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions. Blood 2002; 100: 3400.
18. + T cell responses. J Immunol 2010; 185: 2004.
19. Denecke C, Bedi DS, Ge X, et al. Prolonged graft survival in older recipient mice is determined by impaired effector T-cell but intact regulatory T-cell responses. PLoS One 2010; 5: e9232.
20. Wang L, Xie Y, Zhu LJ, et al. An association between immunosenescence and CD4(+)CD25(+) regulatory T cells: a systematic review. Biomed Environ Sci 2010; 23: 327.
21. Hale JS, Boursalian TE, Turk GL, et al. Thymic output in aged mice. Proc Natl Acad Sci USA 2006; 103: 8447.
22. Wekerle T, Kurtz J, Ito H, et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 2000; 6: 464.
23. Herndler-Brandstetter D, Landgraf K, Tzankov A, et al. The impact of aging on memory T cell phenotype and function in the human bone marrow. J Leukoc Biol 2012; 91: 197.
24. Saule P, Trauet J, Dutriez V, et al. Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment. Mech Ageing Dev 2006; 127: 274.
25. Bigenzahn S, Blaha P, Koporc Z, et al. The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade. Am J Transplant 2005; 5: 1237.
26. High KP, Akbar AN, Nikolich-Zugich J. Translational research in immune senescence: assessing the relevance of current models. Semin Immunol 2012; 24: 373.
27. + regulatory T cells in aged BALB/c mice. J Leukoc Biol 2007; 81: 1386.
28. high regulatory T cells increases with age. Clin Exp Immunol 2005; 140: 540.
29. Rosenkranz D, Weyer S, Tolosa E, et al. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration. J Neuroimmunol 2007; 188: 117.
30. Lages CS, Suffia I, Velilla PA, et al. Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J Immunol 2008; 181: 1835.
31. + Treg cells reveals an age-dependent loss of sup-pressive activity. J Neurosci Res 2003; 74: 296.
32. Pilat N, Baranyi U, Klaus C, et al. Treg-therapy allows mixed chime-rism and transplantation tolerance without cytoreductive conditioning. Am J Transplant 2010; 10: 751.
33. Lakkis FG, Sayegh MH. Memory T cells: a hurdle to immunologic tolerance. J Am Soc Nephrol 2003; 14: 2402.
34. Welsh RM, Selin LK. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol 2002; 2: 417.
35. Williams MA, Tan JT, Adams AB, et al. Characterization of virusmediated inhibition of mixed chimerism and allospecific tolerance. J Immunol 2001; 167: 4987.
36. Wang T, Chen L, Ahmed E, et al. Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes. J Immunol 2008; 180: 5991.
37. Williams MA, Onami TM, Adams AB, et al. Cutting edge: persistent viral infection prevents tolerance induction and escapes immune control following CD28/CD40 blockade-based regimen. J Immunol 2002; 169: 5387.
38. Su LF, Kidd BA, Han A, et al. Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults. Immunity 2013; 38: 373.
39. + T cell repertoire in unimmunized mice includes memory phe-notype cells bearing markers of homeostatic expansion. J Exp Med 2009; 206: 435.
40. Neujahr DC, Chen C, Huang X, et al. Accelerated memory cell ho-meostasis during T cell depletion and approaches to overcome it. J Immunol 2006; 176: 4632.
41. Tchao NK, Turka LA. Lymphodepletion and homeostatic proliferation: implications for transplantation. Am J Transplant 2012; 12: 1079.
42. Surh CD, Boyman O, Purton JF, et al. Homeostasis of memory T cells. Immunol Rev 2006; 211: 154.
43. Cho BK, Rao VP, Ge Q, et al. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells. J Exp Med 2000; 192: 549.
44. Pearl JP, Parris J, Hale DA, et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005; 5: 465.
45. Taylor DK, Neujahr D, Turka LA. Heterologous immunity and ho-meostatic proliferation as barriers to tolerance. Curr Opin Immunol 2004; 16: 558.
46. Ferrara JL, Levine JE, Reddy P, et al. Graft-versus-host disease. Lancet 2009; 373: 1550.
47. Ordemann R, Hutchinson R, Friedman J, et al. Enhanced allo-stimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest 2002; 109: 1249.
48. Brandacher G, Maglione M, Schneeberger S, et al. Tetrahydrobiopterin compounds prolong allograft survival independently of their effect on nitric oxide synthase activity. Transplantation 2006; 81: 583.
49. Wang Q, Liu Y, Li XK. Simplified technique for heterotopic vascularized cervical heart transplantation in mice. Microsurgery 2005; 25: 76.
50. Pascher A, Reutzel-Selke A, Jurisch A, et al. Alterations of the immune response with increasing recipient age are associated with reduced long-term organ graft function of rat kidney allografts. Transplantation 2003; 76: 1560.
51. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710.